ArticleInternational urogynecology journal2026
Outcomes of Redo Dorsal Onlay Buccal Mucosal Graft Urethroplasty After Failed Ventral Urethroplasty in Women.
Article in International urogynecology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Dorsal inlay lingual mucosa graft urethroplasty with artificial dermis donor repair for female urethral stricture.World journal of urology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introduction and hypothesisTo present the outcomes of dorsal onlay (DO) BMG urethroplasty cases after primary urethroplasty failure.
methodsA total of 45 patients who had BMG urethroplasty were retrospectively reviewed. Nine patients who had unsuccessful primary urethroplasty and underwent redo dorsal onlay BMG urethroplasty were identified. Failure was defined as a Qmax of less than 12 mL/s in a symptomatic patient, an inability to calibrate with an 12 Fr catheter, or the necessity for any intervention, including dilation during the follow-up period.
resultsThe median age was 56 years. All patients presented with a history of urethral dilatation and urethroplasty. The baseline median maximum urinary flow rate(Qmax) was 6.5 mL/s, and the median post-void residual (PVR) was 55 mL. The majority of strictures were located in the distal urethra, with stricture lengths ranging from 1.5 to 3 cm. Postoperative functional outcomes demonstrated a significant improvement, with a median postoperative Qmax of 26 mL/s (p = 0.006) and a median PVR of 27 mL (p = 0.043). None of the patients experienced de novo stress urinary incontinence following DO-BMG urethroplasty. No patient experienced bleeding requiring transfusion. The median follow-up duration was 18 months. The success rate was 77.8% over a median follow-up period of 18 months.
conclusionsThe dorsal onlay BMG urethroplasty can be a feasible option in selected cases who have previously had ventral urethroplasty and experienced recurrence. The results of this study which shows high success and low complication rates, are encouraging; however, more studies with larger patient populations are needed to validate its efficacy in the treatment of recurrent FUS.
Indexed as
Identifiers
41945097What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.